Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2425–2448 of 7,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Control Clear all

Conditions: Post Traumatic Stress Disorder PTSD
Interventions: NurseNET, Referral to PTSD Treatment; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Chicago, Illinois • Brookfield, Wisconsin

Conditions: Anterior Cruciate Ligament Injury, Knee Osteoarthritis
Interventions: Therapeutic Intervention; Other
Lead sponsor: Keller Army Community Hospital; Federal
Eligibility: 18 Years to 50 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: West Point, New York

Conditions: Obesity, Childhood, Short Sleep, Obesity Prevention
Interventions: Optimize Sleep Primary Care (OSPC), Enhanced Usual Care; Behavioral · Other
Lead sponsor: Temple University; Other
Eligibility: 6 Years to 11 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Social Stigma, Substance Use Disorders, Mental Disorder
Interventions: Multi-level stigma reduction intervention: educational training plus controlled substance agreement policy change, Single-level stigma reduction intervention: educational training; Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Systemic Lupus Erythematosus
Interventions: Belimumab 10 mg/kg, Placebo; Drug · Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 5 Years to 17 Years
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2025
U.S. locations: 7
States / cities: Phoenix, Arizona • Washington D.C., District of Columbia • Augusta, Georgia + 4 more

Conditions: Hypertension, Stroke, TIA, Vascular Diseases
Interventions: Use of Omron Home Blood Pressure Cuff; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Cardiac Arrest, Out-Of-Hospital
Interventions: CPR Training, CPR Manikin Type; Behavioral · Device
Lead sponsor: University of Nevada, Reno; Other
Eligibility: Not listed
Enrollment: 2,100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Reno, Nevada

Conditions: Diabetes Mellitus, Type 2
Interventions: FRESH; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Desmoplastic Small Round Cell Tumor, Ewing Sarcoma of Bone or Soft Tissue, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Interventions: vincristine, doxorubicin, cyclophosphamide, ifosfamide, etoposide, temozolomide, temsirolimus, bevacizumab, sorafenib, surgery, radiation; Drug · Procedure · Radiation
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 25 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2026
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Adenoma Colon Polyp
Interventions: Not listed
Lead sponsor: AdventHealth; Other
Eligibility: 18 Years and older
Enrollment: 342 participants
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Gestational Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus
Interventions: Fresh Funds for Mom's, Standard Medical care, Medically Tailored Frozen Meals; Behavioral
Lead sponsor: Alison Gustafson; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Lexington, Kentucky • Louisville, Kentucky

Conditions: Chemotherapy-related Cognitive Dysfunction
Interventions: Memory and Attention Adaptation Training (MAAT), Supportive Therapy (ST); Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Indianapolis, Indiana • Pittsburgh, Pennsylvania

Conditions: Pain, Mood, Patient Satisfaction, Scheduled Cesarean Sections
Interventions: Lavender-sandalwood aromatherapy tabs; Other
Lead sponsor: Memorial Hermann Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Tobacco Dependence
Interventions: Innovative System, Standard Treatment Control (STC); Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Contraception, Ovulation Inhibition, Contraceptives, Oral
Interventions: EE20/DRSP (BAY86-5300), EE20/DRSP (YAZ, BAY86-5300); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 1,887 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 85
States / cities: Montgomery, Alabama • Chandler, Arizona • Mesa, Arizona + 74 more

Conditions: Breast Cancer
Interventions: Education brochure, Live education and exercise instruction; Other
Lead sponsor: Oakland University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Saginaw, Michigan

Conditions: Colorectal Cancer
Interventions: Telisotuzumab adizutecan, Bevacizumab, Trifluridine/Tipiracil; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 990 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 18
States / cities: Goodyear, Arizona • Springdale, Arkansas • Duarte, California + 15 more

Conditions: Pediatric Obesity
Interventions: Healthy Eating for My Infant; Behavioral
Lead sponsor: University of Cincinnati; Other
Eligibility: 2 Months to 9 Months
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Cincinnati, Ohio

Conditions: Suicide, Interpersonal Relations
Interventions: VA Standard Suicide Intervention, Treatment for Relationships and Safety Together (TR&ST); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: San Diego, California

Conditions: Liver Cancer
Interventions: nomogram-based selection for acute normovolemic hemodilution, standard selection for ANH based on a planned resection of 3 or more segments; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Metastatic Breast Cancer
Interventions: Enobosarm, Exemestane; Drug
Lead sponsor: Veru Inc.; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 34
States / cities: Chandler, Arizona • Gilbert, Arizona • Glendale, California + 29 more

Conditions: Dialysis
Interventions: Algorithm model-based Aranesp doses, Standard of care; Procedure
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Murray, Utah

Conditions: Women's Health, Annual Visit, Well Visit, Health Behavior, Prevention
Interventions: Precision nudging, Standard of care; Other
Lead sponsor: Lirio; Industry
Eligibility: 21 Years to 65 Years · Female only
Enrollment: 30,068 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Inhalation Injury, Pneumonitis, Pneumonia
Interventions: bronchoscopy; Procedure
Lead sponsor: Hurley Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Flint, Michigan

Search by objective public record fields.

Nurse-Led PTSD Treatment in Primary Care

Gait Retraining Enhances Athletes' Technique

Brief Behavioral Sleep Intervention for Obesity Prevention in Primary Care

Multi-Level Stigma Intervention for Mental Health Services

Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy

Improving Blood Pressure Control in Stroke Patients by Increasing Access to a Home Blood Pressure Monitor

Gathering Evidence on Best Practices for Lay Rescuer CPR Training

Food and Resources Expanded to Support Health and Type 2 Diabetes

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

Fresh Carts for Mom's to Improve Food Security and Glucose Management

Telehealth and Memory Study

Lavender Sandalwood Aromatherapy Study

Tobacco Intervention in Buprenorphine Treatment

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

The Effects of Pre-operative Physical Therapy Education

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Healthy Eating for My Infant (HEMI)

Treatment for Relationships and Safety Together

Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection

Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer

Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease Using the Dialysis Anemia TReatmenT Model

Precision Nudging Drives Wellness Visit Attendance at Scale

Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients